Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6ATAC37P represents a pseudogene for the small nuclear RNA U6atac, annotated as the 37th copy in the human genome. Pseudogenes like RNU6ATAC37P are typically non-functional genomic DNA sequences resembling functional genes, but they generally do not produce active RNA or protein products. RNU6ATAC37P itself is not expressed as a small nuclear RNA and does not participate in biological processes such as pre-mRNA splicing. The canonical U6atac small nuclear RNA is involved in the minor spliceosome complex, essential for the removal of U12-type introns during mRNA splicing, but pseudogene copies do not contribute to this activity[1][4]. RNU6ATAC37P is not considered a therapeutic target, biomarker, or participant in any known drug interaction. Key information indicating this entry is a pseudogene and not a molecular target: - The suffix "P" and the term "pseudogene" indicate a sequence annotated as derived from a functional gene but now considered non-functional[1][4]. - There is no evidence for its involvement in any specific biological pathway, disease mechanism, or drug action[1]. - It is not classified with typical target families such as "Receptor," "Enzyme," or similar; instead, it is a member of the "Other" category, specifically as a pseudogene. For comprehensive and structured information, RNU6ATAC37P should be filtered out in drug target pipelines or therapeutic databases since it does not represent a valid druggable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6atac small nuclear 37, pseudogene (RNU6ATAC37P).